πŸ‡±πŸ‡° Country Profile

Sri Lanka

Expanding pharmaceutical supply to Sri Lanka

πŸ‡±πŸ‡° $318M
All data from DGCIS India export records (fiscal year, April–March).
$318M
Scale
Sri Lanka's patients receive $318M in Indian pharmaceutical products annually β€” almost entirely finished medicines ready for dispensing.
86%
Medicine
Overwhelmingly finished medicines β€” drug formulations account for 86% of shipments.
2.0Γ—
Trajectory
India's pharmaceutical supply to Sri Lanka has grown 2.0Γ— over the past decade β€” strong, sustained expansion.
Context
Part of India's pharmaceutical supply network across Asia-Pacific.
✦
Impact
Indian pharmaceutical companies have both exported to and invested directly in Sri Lanka β€” building trade and operational presence.
Export Trend DGCIS FY
Pharmaceutical Composition Trend DGCIS CY 2014–2025

All pharma categories from DGCIS (487-code basket)

Category Mix — FY 2025–26 DGCIS
Medicines $274M (86.1%) Medicine Ingredients $23.4M (7.4%) Surgical & Hospital Supplies $12.4M (3.9%) Vaccines $4.5M (1.4%) Traditional & Herbal $4.0M (1.3%)
Top Products — FY 2025–26 DGCIS
Indian Pharma Investment in Sri Lanka Source: RBI ODI Data

Total RBI-approved ODI commitments by Indian pharmaceutical companies into Sri Lanka: $1.6M across 8 filings (2011-2024).